Gonorrhea Therapeutics Market Status and Forecast 2019-2025
Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep penetration of generics, the growth rate is expected to be moderate during the forecast period. Additionally, the advent of new antibiotic-resistant strains will continue to hinder the growth prospects.
The latest trend gaining momentum in the market is Advent of vaccine for prevention of gonorrhea. Gonorrhea is a major public health concern globally. It is considerably affecting the reproductive health of people and increasing the spread of human immunodeficiency virus (HIV). The currently available treatment regimen is unsuccessful in controlling the spread of Neisseria gonorrhoeae due to the rapid emergence of the antibiotic-resistant strains of this bacterium. Therefore, the prevention of the disease seems to be a more appropriate approach for controlling the spread of Neisseria gonorrhoeae.
One of the major drivers for this market is Rising prevalence of disease. The rising prevalence of gonorrhea is a major health concern globally. The disease follows chlamydial infection as the second most common STD in the US. The rising prevalence rate of gonorrhea is due to several factors such as growing awareness, increased healthcare access, availability of diagnostic tests, resistance patterns, reporting practices, and the financial constraints that limit the abilities of public healthcare officials to check the disease pattern precisely.
Report Sample includes:
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology
Get FREE Sample of this Report @ https://www.24marketreports.com/request-sample/global-gonorrhea-therapeutics-2019-2025-136
In 2018, the global Gonorrhea Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Gonorrhea Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gonorrhea Therapeutics development in United States, Europe and China.
The key players covered in this study
- Bharat Pharmaceuticals
- GlaxoSmithKline
- Merck
- Pfizer
- Alopexx Pharmaceuticals
- AstraZeneca
- Debiopharm Group
- Melinta Therapeutics
Market segment by Type, the product can be split into
- Monotherapy
- Dual Therapy
Market segment by Application, split into
- Clinics
- Hospitals
- Others
The study objectives of this report are:
- To analyze global Gonorrhea Therapeutics status, future forecast, growth opportunity, key market and key players.
- To present the Gonorrhea Therapeutics development in United States, Europe and China.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by product type, market and key regions.
What Reports Provides:
- Full in-depth analysis of the parent market
- Important changes in market dynamics
- Segmentation details of the market
- Former, on-going, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional markets
Get the Complete Report & TOC @ https://www.24marketreports.com/life-sciences/global-gonorrhea-therapeutics-2019-2025-136